Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see US equity futures gained on Thursday. Tech stocks saw rallies, with Tesla, Amazon and Netflix all climbing higher in premarket. There's still a glimmer of hope for a late-year rally as investors head into 2023 with a cautious mindset. January 2023 is almost here, and there's a predicted $13 trillion tech revolution on the horizon. Our friend Andy Snyder wants you to know about ONE STOCK behind it that could hand you life-changing profits. Click here to unlock this innovative tech company. Here's a look at the top-moving stocks this morning. Kala Pharmaceuticals (Nasdaq: KALA) Kala Pharmaceuticals is up 31.33% premarket after the FDA accepted their new investigational drug application for pipeline candidate KPI-012 for treating persistent corneal epithelial defect. Kala plans to begin a phase llb study evaluating KPI-012 for treating PCED in the first quarter of 2023. TG Therapeutics (Nasdaq: TGTX) TG Therapeutics is up 8.18% premarket after receiving good news from the U.S. Food and Drug Administration. The FDA approved its Briumvi treatment for relapsing forms of multiple sclerosis. With the approval, Briumvi is expected to launch commercially in the first quarter of 2023. Biotech stocks have been surging in recent weeks. And our friend Alexander Green is pounding the table on a medical device company he's calling 'the biggest investment opportunity in 37 years.' Click here to learn more about humanity's 'Next Big Leap.' |
No comments:
Post a Comment